Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P140009/S142

Deep Brain Stimulation (DBS) Implantable Pulse Generator (IPG) Charger

ABBOTT MEDICAL · Decision date Oct 30, 2026

MEDTECHLEDGER EXPLANATIONP140009/S142

What did the FDA decide?

The FDA recorded decision OK30 on 2026-10-30 for P140009/S142, a 30-Day Notice supplement to Abbott Medical's Deep Brain Stimulation (DBS) Implantable Pulse Generator (IPG) Charger. The supplement reason is listed as a process change involving manufacturer, sterilizer, packager or supplier. The stated scope is qualification of an alternate Metal-Oxide-Semiconductor Field-Effect Transistor (MOSFET) electronic component and supplier.

This action concerns a component and supplier change within the existing PMA, not a new approval of the whole system. The device category is an implanted electrical stimulator for parkinsonian tremor, specialty Neurology, product code MHY. The source record does not include the supplement documents, so the specific MOSFET, supplier identity, qualification testing and any conditions of the decision remain unknown.

The decision code OK30 is not expanded in the source, and no clinical or labeling conclusions follow from this record.

FDA approval order statement

qualification of an alternate MetalOxideSemiconductor Field-Effect Transistor (MOSFET) electronic component and supplier
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Neurology
Decision date
Oct 30, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P140009/S142
Regulatory pathway
PMA supplement
Product code
MHY
Decision code
OK30
Decision date
Oct 30, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Stimulator, electrical, implanted, for parkinsonian tremor.

Product code
MHY
FDA device class
3

For the original device and its historical approval scope, see PMA P140009. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P140009 · Original PMA

    BRIO NEUROSTIMULATION SYSTEM

  2. P140009/S140 · Related supplement

    Deep Brain Stimulation (DBS) Implantable Pulse Generator (IPG) Charger

  3. P140009/S142 received

    Application receipt date recorded by FDA.

  4. P140009/S143 · Related supplement

    Liberta RC Deep Brain Stimulation (DBS) Implantable Pulse Generator

  5. P140009/S141 · Related supplement

    Deep Brain Stimulation (DBS) EPG

  6. P140009/S144 · Related supplement

    Deep Brain Stimulation (DBS) Implantable Pulse Generator (IPG)

  7. P140009/S142 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P140009. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P140009

Product / regulatory recordCompanyPathwayDecision dateSource
ABBOTT MEDICALPMA approvalJun 12, 2015FDA
ABBOTT MEDICALPMA supplementSep 11, 2026FDA
Infinity DBS IPGP140009/S139
ABBOTT MEDICALPMA supplementSep 23, 2026FDA
ABBOTT MEDICALPMA supplementOct 27, 2026FDA
ABBOTT MEDICALPMA supplementOct 28, 2026FDA
ABBOTT MEDICALPMA supplementOct 30, 2026FDA

Explore the linked device profile

Other records with product code MHY

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Abbott Medical

Headquarters
Not reported
Brand website
abbott.com
FDA applicant address
6901 Prestion Rd., Plano, TX, 75024

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records